Clive Zent

20PUBLICATIONS

73CO-AUTHORS

Haematological tumoursHaematologyMolecular targetsCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (20)

Sort by Publication Date:

|Jul 09, 2026

Efficacy of high-frequency low-dose rituximab and acalabrutinib in chronic lymphocytic leukemia.

|Apr 14, 2026

Updated consensus guidelines for the diagnosis and management of patients with HCL and HCL variant.

Clive S Zent, Enrico Tiacci, Robert J Kreitman

|Jan 02, 2025

Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.

Jennifer E Bruno, Christine A Herne, Andrea M Baran

|Jun 08, 2024

Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasms.

Michael Grever, Leslie Andritsos, Mirela Anghelina

|Oct 23, 2023

Response-adapted, time-limited venetoclax, umbralisib, and ublituximab for relapsed/refractory chronic lymphocytic leukemia.

Brian T Hill, Shuo Ma, Clive S Zent

|Jul 24, 2023

Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.

Michael T Brady, Nathan Laniewski, Myla Strawderman

Pageof 4

Frequent Collaborators

Sameer A Parikh

Alessandro Gozzetti

Paul M Barr

Pier Luigi Zinzani

Tadeusz Robak

James S Blachly

John F Seymour

Charles C Chu

Narendranath Epperla

AnnaLynn M Williams

Frequent Collaborators

Sameer A Parikh

Alessandro Gozzetti

Paul M Barr

Pier Luigi Zinzani